134 related articles for article (PubMed ID: 36348568)
21. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
Chen L; Chu F; Cao Y; Shao J; Wang F
Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
[TBL] [Abstract][Full Text] [Related]
22. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage.
Lin L; Lu B; Yu J; Liu W; Zhou A
Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963
[TBL] [Abstract][Full Text] [Related]
23. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
[TBL] [Abstract][Full Text] [Related]
24. Circulating MicroRNA-122 for the Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis.
Zhao XF; Li N; Lin DD; Sun LB
Biomed Res Int; 2020; 2020():5353695. PubMed ID: 32309434
[TBL] [Abstract][Full Text] [Related]
25. The predictive powers of plasma trefoil factor 3 or its related micro RNAs for patients with hepatocellular carcinoma.
Zhang C; Xia R; Zhang B; Wang H
BMC Cancer; 2018 Nov; 18(1):1110. PubMed ID: 30424721
[TBL] [Abstract][Full Text] [Related]
26. Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus.
Hung CH; Hu TH; Lu SN; Kuo FY; Chen CH; Wang JH; Huang CM; Lee CM; Lin CY; Yen YH; Chiu YC
Int J Cancer; 2016 Feb; 138(3):714-20. PubMed ID: 26264553
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNAs as biomarkers for the diagnosis of hepatocellular carcinoma: A meta-analysis.
Zeng C; Tang Y; Jiang Y; Zuo Z; Tao H
Pathol Res Pract; 2021 Aug; 224():153546. PubMed ID: 34332221
[TBL] [Abstract][Full Text] [Related]
28. Serum miR-483-5p and miR-133a as Biomarkers for Diagnosis of Hepatocellular Carcinoma Post-Hepatitis C Infection in Egyptian Patients.
Hassan AS; Elgendy NA; Tawfik NA; Elnasser AM
Egypt J Immunol; 2019 Jul; 26(2):31-40. PubMed ID: 31926493
[TBL] [Abstract][Full Text] [Related]
29. Circulating microRNAs as biomarkers for hepatocellular carcinoma.
Qu KZ; Zhang K; Li H; Afdhal NH; Albitar M
J Clin Gastroenterol; 2011 Apr; 45(4):355-60. PubMed ID: 21278583
[TBL] [Abstract][Full Text] [Related]
30. Circulating miRNA-199a and miRNA-122 Levels as Potential Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma.
Wu J; Wu Y; Luo Y; Li X; Lin N; Yang X; Lin Y; Chen M
Ann Clin Lab Sci; 2020 Mar; 50(2):219-227. PubMed ID: 32366560
[TBL] [Abstract][Full Text] [Related]
31. Circulating miR-130b- and miR-21-based diagnostic markers and therapeutic targets for hepatocellular carcinoma.
Zhang N; Hu Z; Qiang Y; Zhu X
Mol Genet Genomic Med; 2019 Dec; 7(12):e1012. PubMed ID: 31660696
[TBL] [Abstract][Full Text] [Related]
32. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yu F; Lu Z; Chen B; Dong P; Zheng J
Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-122 as a diagnostic biomarker for hepatocellular carcinoma related to hepatitis C virus: a meta-analysis and systematic review.
Wei XY; Ding J; Tian WG; Yu YC
J Int Med Res; 2020 Aug; 48(8):300060520941634. PubMed ID: 32790532
[TBL] [Abstract][Full Text] [Related]
34. Development and Validation of a Novel Circulating miRNA-Based Diagnostic Score for Early Detection of Hepatocellular Carcinoma.
Yu B; Zhou S; Liang H; Ye Q; Wang Y
Dig Dis Sci; 2022 Jun; 67(6):2283-2292. PubMed ID: 33982217
[TBL] [Abstract][Full Text] [Related]
35. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
[TBL] [Abstract][Full Text] [Related]
36. Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis.
Xu Y; Li L; Xiang X; Wang H; Cai W; Xie J; Han Y; Bao S; Xie Q
Gene; 2013 Sep; 527(2):584-93. PubMed ID: 23791656
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic accuracy of circulating microRNA in hepatitis B virus-related hepatocellular carcinoma: a meta-analysis based on Asian data.
Zhang WT; Gil-Gómez A; Liu CH; Gao SS; Romero-Gómez M
Rev Esp Enferm Dig; 2022 May; 114(5):280-288. PubMed ID: 34423645
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of miR-331-3p and miR-23b-3p as serum biomarkers for hepatitis c virus-related hepatocellular carcinoma at early stage.
Sun Q; Li J; Jin B; Wang T; Gu J
Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):21-28. PubMed ID: 31053500
[TBL] [Abstract][Full Text] [Related]
39. Circulating MicroRNA Panel as a Diagnostic Marker for Hepatocellular Carcinoma.
Wu X; Wan R; Ren L; Yang Y; Ding Y; Wang W
Turk J Gastroenterol; 2022 Oct; 33(10):844-851. PubMed ID: 35943150
[TBL] [Abstract][Full Text] [Related]
40. Functional miR-146a, miR-149, miR-196a2 and miR-499 polymorphisms and the susceptibility to hepatocellular carcinoma: An updated meta-analysis.
Zheng L; Zhuang C; Zhao J; Ming L
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):664-676. PubMed ID: 28499985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]